CN102146039B - 一种吉法酯化合物的合成工艺 - Google Patents
一种吉法酯化合物的合成工艺 Download PDFInfo
- Publication number
- CN102146039B CN102146039B CN 201110021222 CN201110021222A CN102146039B CN 102146039 B CN102146039 B CN 102146039B CN 201110021222 CN201110021222 CN 201110021222 CN 201110021222 A CN201110021222 A CN 201110021222A CN 102146039 B CN102146039 B CN 102146039B
- Authority
- CN
- China
- Prior art keywords
- gefarnate
- washing
- distilling
- mol ratio
- reduced pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920001386 Gefarnate Polymers 0.000 title claims abstract description 20
- 229960003779 gefarnate Drugs 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title claims abstract description 13
- -1 gefarnate compound Chemical class 0.000 title claims abstract description 6
- 230000002194 synthesizing effect Effects 0.000 title abstract 2
- ZPACYDRSPFRDHO-ROBAGEODSA-N Gefarnate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CCC(=O)OC\C=C(/C)CCC=C(C)C ZPACYDRSPFRDHO-ROBAGEODSA-N 0.000 claims abstract description 14
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000005406 washing Methods 0.000 claims abstract description 9
- 239000002904 solvent Substances 0.000 claims abstract description 8
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims abstract description 7
- 239000005792 Geraniol Substances 0.000 claims abstract description 7
- 229940113087 geraniol Drugs 0.000 claims abstract description 7
- 238000010438 heat treatment Methods 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 claims abstract description 5
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 claims abstract description 4
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 claims abstract description 4
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 claims abstract description 4
- 239000012074 organic phase Substances 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims abstract description 3
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- 238000003786 synthesis reaction Methods 0.000 claims description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 238000004821 distillation Methods 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 4
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 239000012071 phase Substances 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 abstract description 5
- 238000001914 filtration Methods 0.000 abstract description 2
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 abstract 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 abstract 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 abstract 1
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 0 CC(*)C(C)CCC(*)=CNCC(C)=*CC* Chemical compound CC(*)C(C)CCC(*)=CNCC(C)=*CC* 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 206010061164 Gastric mucosal lesion Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000024981 pyrosis Diseases 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110021222 CN102146039B (zh) | 2011-01-19 | 2011-01-19 | 一种吉法酯化合物的合成工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110021222 CN102146039B (zh) | 2011-01-19 | 2011-01-19 | 一种吉法酯化合物的合成工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102146039A CN102146039A (zh) | 2011-08-10 |
CN102146039B true CN102146039B (zh) | 2013-06-05 |
Family
ID=44420534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110021222 Active CN102146039B (zh) | 2011-01-19 | 2011-01-19 | 一种吉法酯化合物的合成工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102146039B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102399141A (zh) * | 2011-09-09 | 2012-04-04 | 南京瑞尔医药有限公司 | 一种新的吉法酯关键中间体的制备方法 |
CN103012140B (zh) * | 2013-01-08 | 2016-02-17 | 湖南方盛制药股份有限公司 | 吉法酯的制备方法 |
CN104370731A (zh) * | 2013-08-15 | 2015-02-25 | 南京瑞尔医药有限公司 | 一种吉法酯关键中间体的精制或反应液直接后处理的方法 |
CN103614426B (zh) * | 2013-11-20 | 2016-06-15 | 湖北理工学院 | 一种制备吉法酯的方法 |
CN105439889B (zh) * | 2015-11-20 | 2017-08-22 | 安徽省逸欣铭医药科技有限公司 | 一种香兰素胺类新化合物、其制备方法及医药用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101475476A (zh) * | 2009-01-21 | 2009-07-08 | 海南美大制药有限公司 | 一种吉法酯化合物及其合成方法 |
CN101805260A (zh) * | 2010-04-06 | 2010-08-18 | 蔡伦 | 一种吉法酯的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS504021A (zh) * | 1973-05-17 | 1975-01-16 | ||
JPS53103412A (en) * | 1977-02-18 | 1978-09-08 | Kuraray Co Ltd | Preparation of farnesyl acetic acid or its ester |
-
2011
- 2011-01-19 CN CN 201110021222 patent/CN102146039B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101475476A (zh) * | 2009-01-21 | 2009-07-08 | 海南美大制药有限公司 | 一种吉法酯化合物及其合成方法 |
CN101805260A (zh) * | 2010-04-06 | 2010-08-18 | 蔡伦 | 一种吉法酯的制备方法 |
Non-Patent Citations (2)
Title |
---|
JP昭53-103412A 1978.09.08 |
JP特开昭50-4021A 1975.01.16 |
Also Published As
Publication number | Publication date |
---|---|
CN102146039A (zh) | 2011-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102146039B (zh) | 一种吉法酯化合物的合成工艺 | |
CN101570550B (zh) | 手性二茂铁类双膦配体的合成方法 | |
CN110437294A (zh) | 一种制备群勃龙醋酸酯的方法 | |
CN102153585A (zh) | 一种米诺膦酸中间体的合成方法及米诺膦酸的合成 | |
CN102206151B (zh) | 王浆酸的合成方法 | |
CN102731605B (zh) | 一种醋酸阿比特龙的纯化方法 | |
CN101830893A (zh) | 一种拉米夫定中间体hdms的合成制备工艺 | |
CN103360350A (zh) | 一种适于工业化生产、高纯度的注射用炎琥宁的制备方法 | |
CN101519361A (zh) | 左氧氟沙星和氧氟沙星的制备方法 | |
CN103897025B (zh) | 一种匹多莫德的制备方法 | |
CN103012140B (zh) | 吉法酯的制备方法 | |
CN103113294B (zh) | 瑞巴派特的合成方法 | |
CN101805260B (zh) | 一种吉法酯的制备方法 | |
CN103145636A (zh) | 一种1,4-二酰基-3,6-二苯基-1,4-二氢均四嗪类化合物及其制备方法和应用 | |
CN102816060B (zh) | 高纯度克利贝特的制备方法 | |
CN104761599A (zh) | 一种5,4’-二羟基黄酮-7-o-d-葡萄糖醛酸的制备方法 | |
CN111533718B (zh) | 一种制备苯溴马隆的方法 | |
CN101245067B (zh) | 一种恩替卡韦的制备方法及其中间体 | |
CN104513186B (zh) | 一种光学纯的右旋氯前列醇钠的制备方法 | |
CN114213260A (zh) | 一种普罗碘铵的制备方法 | |
CN104529726B (zh) | 一种邻羟基苯乙酮的制备方法 | |
CN103319455B (zh) | 一种高纯度雷尼酸锶的制备方法 | |
CN102180864A (zh) | 一种雷尼酸锶的制备方法 | |
CN102050775B (zh) | 阿那曲唑杂质α,α,α′,α′-四甲基-5-(丁二酰亚胺-1-基甲基)-1,3-苯二乙腈及其制备方法 | |
CN114105737B (zh) | 一种阿维a的中间体的制备方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Cui Dongdong Inventor after: Wu Yiyan Inventor after: Zhao Yujia Inventor after: Zhao Junchang Inventor after: Han Ruiting Inventor after: Cai Wei Inventor after: Ren Yulan Inventor after: Xu Chunlin Inventor before: Cui Dongdong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CUI DONGDONG TO: CUI DONGDONG WU YIYAN ZHAO YUJIA ZHAO JUNCHANG HAN RUITING CAI WEI REN YULAN XU CHUNLIN |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder |
Address after: 100101 No. 2 building, No. 19, Beiyuan East Road, 2508, Beijing, Chaoyang District, 25 Patentee after: Beijing Lunarsun Medical Technology Co., Ltd. Address before: 100101 Beijing Chaoyang District Anli Road, Sunshine Plaza, No. 68 room C1-802 Patentee before: Beijing Lunarsun Medical Technology Co., Ltd. |
|
CP02 | Change in the address of a patent holder | ||
DD01 | Delivery of document by public notice |
Addressee: Beijing Lunarsun Medical Technology Co., Ltd. Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Wen Ying Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice |